2024.04.15
INNOVATIVE TRANSCATHETER EDGETO-EDGE RE···
On April 12, 2024, the results of GeminiOne® for DMR were published in JACC: Case Reports, a leading···
2024.03.29
Trilogy™ THV SYSTEM FOR AR INDICATION: R···
On March 26, 2024, the exciting results of JenaValve TrilogyTM System’s pivotal clinical trial, ALIG···
2024.03.01
TaurusNXT® NON-GLUTARALDEHYDE CROSSLINKE···
In February 2024, TaurusNXT® Non-glutaraldehyde Crosslinked dry-tissue TAVR system, a thirdgenerati···
2024.02.01
TaurusAtlas Pro, THE SECOND-GENERATION B···
The registration application of TaurusAtlas Pro, the second-generation balloon dilatation catheter i···
2024.01.29
TaurusTrio AR TAVR SYSTEM COMPLETED ALL ···
In January 2024, TaurusTrio AR TAVR System successfully completed patient enrollment in its mu···
2023.12.29
Academic Conferences at Home and Abroad ···
❖ TaurusOne® Transcatheter Aortic Valve Replacement (TAVR) System■ Four-Year Clinical Follow-up Resu···
2023.12.22
Shanghai Renji Hospital Completed the Fi···
Achieva Medical initiated a prospective, multi-center, randomized-controlled clinical trial to evalu···
2023.11.01
Prof. Yu Bo's Team at the Second Affilia···
On October 31, 2023, the team led by Prof. Yu Bo at the Second Affiliated Hospital of Harbin Medical···
2023.07.31
Professor Song Guangyuan and His Team at···
On July 26, 2023, Professor Song Guangyuan, the Director of the Heart Valve Intervention Center at B···
2023.07.07
NMPA APPROVAL FOR REGISTRATION APPLICATI···
This announcement is made by Peijia Medical Limited (the “Company”, together with its
subsidiaries,···
2023.05.18
First Asian Commercial Implants with the···
On May 12th, 2023, Dr. Michael Lee and his team from the Cardiology Department of Queen Elizabeth Ho···
2022.12.04
FIRST PATIENT ENROLLMENT IN THE MULTI-CE···
FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER
REGISTRATION CLINICAL TRIAL OF GeminiOne®
TRANSCATHET···